AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimibeat-M2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Life Drug Pharmaceutical

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimibeat-M2 Tablet SR

DiaBeta-Duo SR tablets are a dual-action antidiabetic medication prescribed for adult patients with type 2 diabetes. This combination therapy helps regulate blood glucose levels. Always take DiaBeta-Duo SR with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-managed blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, incorporating dietary adjustments, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect; familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and treatment. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or significant hepatic or renal impairment. Disclose any history of cardiovascular disease to your physician before commencing treatment. Consult your doctor before using DiaBeta-Duo SR if pregnant or breastfeeding. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glimibeat-M2 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glimibeat-M2 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimibeat-M2 Tablet SR whole; do not crush, chew, or divide it. Administer this medicine with a meal.

Common Side effects of Glimibeat-M2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimibeat-M2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Glimibeat-M2 Tablet SR with a meal.

How Glimibeat-M2 Tablet SR works:

Glimibeat-M2 SR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glimibeat-M2 Tablet SR use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimibeat-M2 Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimibeat-M2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimibeat-M2 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glimibeat-M2 Tablet SR use. Physician consultation is essential. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimibeat-M2 Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with mild to moderate liver disease, Glimibeat-M2 Tablet SR is typically initiated at a low dose; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimibeat-M2 Tablet SR :

Should you forget a Glimibeat-M2 Tablet SR dose, administer it promptly. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimibeat-M2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimibeat-M2 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimibeat-M2 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimibeat-M2 Tablet SR and seek immediate medical attention.
Glimibeat-M2 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glimibeat-M2 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimibeat-M2 Tablet SR use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Glimibeat-M2 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimibeat-M2 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimibeat-M2 Tablet SR
78
MRP 95
17% off